{"entity":{"type":"insider","cik":"0001268854","url":"/insider/0001268854","json_url":"/insider/0001268854.json","name":"SAUNDERS BRENT L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":14,"first":"2007-05-01","last":"2026-03-10","span_basis":"filed_date"},"name_variants":[{"name":"SAUNDERS BRENT L","source":"filing","n_filings":14,"first_seen":"2007-05-01","last_seen":"2026-03-10"}],"transactions":[{"id":5971060,"accession":"0001860742-26-000054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001860742-26-000054","line_url":"/filing/0001860742-26-000054#line-2","is_derivative":false,"issuer_cik":"0001268854","issuer_name":"Bausch & Lomb Corp","issuer_ticker":"BLCO","issuer_name_source":null,"issuer_url":"/issuer/0001268854","owner_cik":"0001268854","owner_name":"SAUNDERS BRENT L","owner_display_name":"SAUNDERS BRENT L","owner_url":"/insider/0001268854","role":"Director, Officer (CEO and Chairman of the Board)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Chairman of the Board","security_title":"Common Shares, No Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14700.0,"shares_display":"14,700","price_per_share":17.14,"price_display":"17.14","price_state":"stated","total_value":251958.0,"total_display":"251,958.00","total_whole":"251,958","shares_owned_after":966575.0,"shares_owned_after_display":"966,575","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-06","filed_date":"2026-03-10","scope":"insider"},{"id":4924721,"accession":"0001127602-25-015582","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-25-015582","line_url":"/filing/0001127602-25-015582#line-2","is_derivative":false,"issuer_cik":"0001268854","issuer_name":"Bausch & Lomb Corp","issuer_ticker":"BLCO","issuer_name_source":null,"issuer_url":"/issuer/0001268854","owner_cik":"0001268854","owner_name":"SAUNDERS BRENT L","owner_display_name":"SAUNDERS BRENT L","owner_url":"/insider/0001268854","role":"Director, Officer (CEO and Chairman of the Board)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Chairman of the Board","security_title":"Common Shares, No Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22000.0,"shares_display":"22,000","price_per_share":11.276,"price_display":"11.28","price_state":"stated","total_value":248072.0,"total_display":"248,072.00","total_whole":"248,072","shares_owned_after":719156.0,"shares_owned_after_display":"719,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-22","filed_date":"2025-05-27","scope":"insider"},{"id":4146525,"accession":"0001415889-25-014185","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-014185","line_url":"/filing/0001415889-25-014185#line-2","is_derivative":false,"issuer_cik":"0001268854","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001268854","owner_cik":"0001268854","owner_name":"SAUNDERS BRENT L","owner_display_name":"SAUNDERS BRENT L","owner_url":"/insider/0001268854","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120000.0,"shares_display":"120,000","price_per_share":14.2502,"price_display":"14.25","price_state":"stated","total_value":1710024.0,"total_display":"1,710,024.00","total_whole":"1,710,024","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-20","filed_date":"2025-05-22","scope":"insider"},{"id":2829928,"accession":"0001628280-24-036967","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-036967","line_url":"/filing/0001628280-24-036967#line-1","is_derivative":false,"issuer_cik":"0001268854","issuer_name":"Beauty Health Co","issuer_ticker":"SKIN","issuer_name_source":null,"issuer_url":"/issuer/0001268854","owner_cik":"0001268854","owner_name":"SAUNDERS BRENT L","owner_display_name":"SAUNDERS BRENT L","owner_url":"/insider/0001268854","role":"Director, Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40450.0,"shares_display":"40,450","price_per_share":1.08,"price_display":"1.08","price_state":"stated","total_value":43686.0,"total_display":"43,686.00","total_whole":"43,686","shares_owned_after":5921769.0,"shares_owned_after_display":"5,921,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-12","filed_date":"2024-08-13","scope":"insider"},{"id":3068843,"accession":"0001127602-24-021823","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-24-021823","line_url":"/filing/0001127602-24-021823#line-2","is_derivative":false,"issuer_cik":"0001268854","issuer_name":"Bausch & Lomb Corp","issuer_ticker":"BLCO","issuer_name_source":null,"issuer_url":"/issuer/0001268854","owner_cik":"0001268854","owner_name":"SAUNDERS BRENT L","owner_display_name":"SAUNDERS BRENT L","owner_url":"/insider/0001268854","role":"Director, Officer (CEO and Chairman of the Board)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Chairman of the Board","security_title":"Common Shares, No Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":32250.0,"shares_display":"32,250","price_per_share":15.661,"price_display":"15.66","price_state":"stated","total_value":505067.25,"total_display":"505,067.25","total_whole":"505,067","shares_owned_after":595169.0,"shares_owned_after_display":"595,169","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-05","filed_date":"2024-08-07","scope":"insider"},{"id":8715974,"accession":"0001628280-23-029854","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-029854","line_url":"/filing/0001628280-23-029854#line-1","is_derivative":false,"issuer_cik":"0001268854","issuer_name":"Beauty Health Co","issuer_ticker":"SKIN","issuer_name_source":null,"issuer_url":"/issuer/0001268854","owner_cik":"0001268854","owner_name":"SAUNDERS BRENT L","owner_display_name":"SAUNDERS BRENT L","owner_url":"/insider/0001268854","role":"Director, Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":59380.0,"shares_display":"59,380","price_per_share":6.1026,"price_display":"6.10","price_state":"stated","total_value":362372.388,"total_display":"362,372.39","total_whole":"362,372","shares_owned_after":5827453.0,"shares_owned_after_display":"5,827,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-16","filed_date":"2023-08-17","scope":"insider"},{"id":6669638,"accession":"0000899243-22-000193","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-000193","line_url":"/filing/0000899243-22-000193#line-1","is_derivative":false,"issuer_cik":"0001268854","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001268854","owner_cik":"0001268854","owner_name":"SAUNDERS BRENT L","owner_display_name":"SAUNDERS BRENT L","owner_url":"/insider/0001268854","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17600.0,"shares_display":"17,600","price_per_share":14.4818,"price_display":"14.48","price_state":"stated","total_value":254879.68,"total_display":"254,879.68","total_whole":"254,880","shares_owned_after":17600.0,"shares_owned_after_display":"17,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-29","filed_date":"2022-01-03","scope":"insider"},{"id":8770035,"accession":"0001179110-19-003505","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-19-003505","line_url":"/filing/0001179110-19-003505","is_derivative":false,"issuer_cik":"0001268854","issuer_name":"Allergan plc","issuer_ticker":"AGN","issuer_name_source":null,"issuer_url":"/issuer/0001268854","owner_cik":"0001268854","owner_name":"SAUNDERS BRENT L","owner_display_name":"SAUNDERS BRENT L","owner_url":"/insider/0001268854","role":"Director, Officer (Chairman, President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman, President and CEO","security_title":"Ordinary Shares, par value $0.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1760.0,"shares_display":"1,760","price_per_share":143.66931818181817,"price_display":"143.67","price_state":"stated","total_value":252858.0,"total_display":"252,858.00","total_whole":"252,858","shares_owned_after":170066.29,"shares_owned_after_display":"170,066.29","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-07","filed_date":"2019-03-07","scope":"insider","n_lines":3},{"id":6095840,"accession":"0001179110-18-003827","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-18-003827","line_url":"/filing/0001179110-18-003827#line-1","is_derivative":false,"issuer_cik":"0001268854","issuer_name":"Allergan plc","issuer_ticker":"AGN","issuer_name_source":null,"issuer_url":"/issuer/0001268854","owner_cik":"0001268854","owner_name":"SAUNDERS BRENT L","owner_display_name":"SAUNDERS BRENT L","owner_url":"/insider/0001268854","role":"Director, Officer (Chairman, President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman, President and CEO","security_title":"Ordinary Shares, par value $0.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3300.0,"shares_display":"3,300","price_per_share":152.53,"price_display":"152.53","price_state":"stated","total_value":503349.0,"total_display":"503,349.00","total_whole":"503,349","shares_owned_after":180931.29,"shares_owned_after_display":"180,931.29","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-08","filed_date":"2018-03-08","scope":"insider"},{"id":5249618,"accession":"0001179110-17-014997","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-17-014997","line_url":"/filing/0001179110-17-014997","is_derivative":false,"issuer_cik":"0001268854","issuer_name":"Allergan plc","issuer_ticker":"AGN","issuer_name_source":null,"issuer_url":"/issuer/0001268854","owner_cik":"0001268854","owner_name":"SAUNDERS BRENT L","owner_display_name":"SAUNDERS BRENT L","owner_url":"/insider/0001268854","role":"Director, Officer (Chairman, President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman, President and CEO","security_title":"Ordinary Shares, par value $0.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4600.0,"shares_display":"4,600","price_per_share":164.73782608695652,"price_display":"164.74","price_state":"stated","total_value":757794.0,"total_display":"757,794.00","total_whole":"757,794","shares_owned_after":186177.29,"shares_owned_after_display":"186,177.29","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-06","filed_date":"2017-12-06","scope":"insider","n_lines":2},{"id":4072929,"accession":"0001179110-17-012396","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-17-012396","line_url":"/filing/0001179110-17-012396#line-2","is_derivative":false,"issuer_cik":"0001268854","issuer_name":"Allergan plc","issuer_ticker":"AGN","issuer_name_source":null,"issuer_url":"/issuer/0001268854","owner_cik":"0001268854","owner_name":"SAUNDERS BRENT L","owner_display_name":"SAUNDERS BRENT L","owner_url":"/insider/0001268854","role":"Director, Officer (Chairman, President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman, President and CEO","security_title":"Ordinary Shares, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":43.768,"shares_display":"43.77","price_per_share":235.96,"price_display":"235.96","price_state":"stated","total_value":10327.49728,"total_display":"10,327.50","total_whole":"10,327","shares_owned_after":131178.29,"shares_owned_after_display":"131,178.29","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-16","filed_date":"2017-09-18","scope":"insider"},{"id":4072926,"accession":"0001179110-17-012396","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-17-012396","line_url":"/filing/0001179110-17-012396#line-1","is_derivative":false,"issuer_cik":"0001268854","issuer_name":"Allergan plc","issuer_ticker":"AGN","issuer_name_source":null,"issuer_url":"/issuer/0001268854","owner_cik":"0001268854","owner_name":"SAUNDERS BRENT L","owner_display_name":"SAUNDERS BRENT L","owner_url":"/insider/0001268854","role":"Director, Officer (Chairman, President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman, President and CEO","security_title":"Ordinary Shares, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":42.52,"shares_display":"42.52","price_per_share":242.21,"price_display":"242.21","price_state":"stated","total_value":10298.7692,"total_display":"10,298.77","total_whole":"10,299","shares_owned_after":131134.52,"shares_owned_after_display":"131,134.52","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-29","filed_date":"2017-09-18","scope":"insider"},{"id":2124913,"accession":"0001179110-16-031890","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-16-031890","line_url":"/filing/0001179110-16-031890#line-1","is_derivative":false,"issuer_cik":"0001268854","issuer_name":"Allergan plc","issuer_ticker":"AGN","issuer_name_source":null,"issuer_url":"/issuer/0001268854","owner_cik":"0001268854","owner_name":"SAUNDERS BRENT L","owner_display_name":"SAUNDERS BRENT L","owner_url":"/insider/0001268854","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Ordinary Shares, par value $0.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5250.0,"shares_display":"5,250","price_per_share":189.1316,"price_display":"189.13","price_state":"stated","total_value":992940.9,"total_display":"992,940.90","total_whole":"992,941","shares_owned_after":106564.0,"shares_owned_after_display":"106,564","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-21","filed_date":"2016-11-21","scope":"insider"},{"id":8479389,"accession":"0001179110-15-012557","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-012557","line_url":"/filing/0001179110-15-012557#line-1","is_derivative":false,"issuer_cik":"0001268854","issuer_name":"Allergan plc","issuer_ticker":"AGN","issuer_name_source":null,"issuer_url":"/issuer/0001268854","owner_cik":"0001268854","owner_name":"SAUNDERS BRENT L","owner_display_name":"SAUNDERS BRENT L","owner_url":"/insider/0001268854","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Ordinary shares, par value $0.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":301.94,"price_display":"301.94","price_state":"stated","total_value":301940.0,"total_display":"301,940.00","total_whole":"301,940","shares_owned_after":132862.0,"shares_owned_after_display":"132,862","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-21","filed_date":"2015-08-24","scope":"insider"},{"id":7447532,"accession":"0000310158-07-000016","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000310158-07-000016","line_url":"/filing/0000310158-07-000016","is_derivative":false,"issuer_cik":"0000310158","issuer_name":"SCHERING PLOUGH CORP","issuer_ticker":"SGP","issuer_name_source":null,"issuer_url":"/issuer/0000310158","owner_cik":"0001268854","owner_name":"SAUNDERS BRENT L","owner_display_name":"SAUNDERS BRENT L","owner_url":"/insider/0001268854","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35529.0,"shares_display":"35,529","price_per_share":31.63934898252132,"price_display":"31.64","price_state":"stated","total_value":1124114.43,"total_display":"1,124,114.43","total_whole":"1,124,114","shares_owned_after":36359.0,"shares_owned_after_display":"36,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-04-27","filed_date":"2007-05-01","scope":"insider","n_lines":6}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":16,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001860742","name":"Bausch & Lomb Corp","url":"/issuer/0001860742","role":"Director, Officer (CEO and Chairman of the Board)","n_filings":3,"first_seen":"2024-08-07","last_seen":"2026-03-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001671858","name":"ARS Pharmaceuticals, Inc.","url":"/issuer/0001671858","role":"Director","n_filings":1,"first_seen":"2025-05-22","last_seen":"2025-05-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001818093","name":"Beauty Health Co","url":"/issuer/0001818093","role":"Director, Other","n_filings":2,"first_seen":"2023-08-17","last_seen":"2024-08-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001743881","name":"BridgeBio Pharma, Inc.","url":"/issuer/0001743881","role":"Director","n_filings":1,"first_seen":"2022-01-03","last_seen":"2022-01-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001578845","name":"Allergan plc","url":"/issuer/0001578845","role":"Director, Officer (Chairman, President and CEO)","n_filings":6,"first_seen":"2015-08-24","last_seen":"2019-03-07"},{"type":"issuer","type_label":"ISSUER","cik":"0000310158","name":"SCHERING PLOUGH CORP","url":"/issuer/0000310158","role":"Officer (Senior Vice President)","n_filings":1,"first_seen":"2007-05-01","last_seen":"2007-05-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001268854","retrieved_at":"2026-08-27T08:42:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}